Skip to main content
PlainMeds

Prescription medicine

Technetium tc 99m sestamibi

Technetium tc 99m sestamibi is a prescription medicine. FDA's NDC Directory lists it from 2 generic labelers.

  • Generic listed

Check it at the source: the technetium tc 99m sestamibi FDA label on DailyMed (effective September 8, 2025); every technetium tc 99m sestamibi label on DailyMed.

Highlights of the record

FDA label of September 8, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Myocardial Imaging: Technetium Tc 99m Sestamibi Injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions.

Forms and strengths

  • 1 mg/5ml
  • 1 mg/ml

Injection (powder) (lyophilized) for solution; injection (powder) for solution.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
2 of which 2 under generic applications, 0 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
281 through July 30, 2026

What is technetium tc 99m sestamibi used for?

From the label: indications and usage

Myocardial Imaging: Technetium Tc 99m Sestamibi Injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. Technetium Tc 99m Sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent’s labeling). […]

FDA pharmacologic class: Radioactive Diagnostic Agent.

Source: FDA drug label (Kit for the Preparation of Technetium Tc99m Sestamibi), Cardinal Health 414, LLC, effective September 8, 2025 (SPL set 8626e756-767a-4a14-9188-658b58185254), via openFDA; the full label on DailyMed

Is there a generic for technetium tc 99m sestamibi?

No generic technetium tc 99m sestamibi is approved (Drugs@FDA, October 8, 2026).

FDA's NDC Directory lists technetium tc 99m sestamibi from 2 labelers under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the technetium tc 99m sestamibi label say about other medicines?

The technetium tc 99m sestamibi label names 1 other medicine in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Tetrakis copper tetrafluoroboratewarnings and precautionsTechnetium Tc 99m labeling reactions depend on maintaining the stannous ion in the reduced state.

Check technetium tc 99m sestamibi against other medicines

Source: FDA drug label (Kit for the Preparation of Technetium Tc99m Sestamibi), Cardinal Health 414, LLC, effective September 8, 2025 (SPL set 8626e756-767a-4a14-9188-658b58185254), via openFDA; the full label on DailyMed

What do FAERS reports show for technetium tc 99m sestamibi?

The FDA Adverse Event Reporting System holds 281 reports that list technetium tc 99m sestamibi among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 9 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Drug Ineffective (a use or a product term, not a reaction)196
  • Off Label Use (a use or a product term, not a reaction)15
  • Product With Quality Issue Administered12
  • Dizziness (named in the label)11
  • Product Preparation Error10
  • Radioisotope Uptake Increased10
  • Rash (named in the label)9
  • Urticaria (named in the label)9

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other radioactive diagnostic agents
the pharmacologic class, with prices and generics
Technetium tc 99m sestamibi side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other